Quarterly report pursuant to Section 13 or 15(d)

Schedule of Reclassification of Condensed Consolidated Balance Sheet Information (Details)

v3.21.2
Schedule of Reclassification of Condensed Consolidated Balance Sheet Information (Details) - USD ($)
Sep. 30, 2021
Jun. 30, 2021
Mar. 31, 2021
Dec. 31, 2020
Sep. 30, 2020
Jun. 30, 2020
Mar. 31, 2020
Jan. 02, 2020
Dec. 31, 2019
Nov. 30, 2019
Cash $ 1,375,014     $ 148,284            
Prepaid expenses 569,825     1,218            
Due from affiliate                  
Total Current Assets       149,502            
Operating Lease Right-of-Use Assets 64,231     527,195       $ 1,014,636    
Intangible Assets, net                  
Total Non-Current Assets 12,062,770     527,195            
Total Assets 28,010,376     676,697            
Trade and Other Payables 2,053,542     1,801,729            
Due to Related Party                  
Interest Payable, related party                  
Loan Payable       1,200,000            
Operating Lease Payable 38,932     481,049            
Paycheck Protection Program Loan       70,600            
Total Current Liabilities 2,092,474     3,553,378            
Line of Credit Payable – related party, net of discount     2,333,984            
Interest Payable, related party                  
Operating Lease Liability, net of current 25,978     46,369       $ 1,016,015    
Total Non-Current Liabilities 25,978     2,380,353            
Total Liabilities 2,118,452     5,933,731            
Commitments and Contingencies                  
STOCKHOLDERS’ DEFICIT                    
Common stock, par $0.0001, 100,000,000 shares authorized and 73,991,413 issued and outstanding as of December 31, 2020     4,004            
Common Stock, No Par Value $ 0                  
Additional Paid in Capital     43,411,487            
Accumulated Deficit (75,321,846)     (48,672,525)            
Total Stockholders’ Equity (Deficit) 25,891,924 $ 31,074,335 $ (8,346,738) (5,257,034) $ (4,227,440) $ (3,051,439) $ (2,664,780)   $ (2,332,831.00) $ (1,726,363)
Total Liabilities and Stockholders’ Equity (Deficit) 28,010,376     676,697            
Trade and Other Payable Non Current       244,485            
Operating Lease, Liability $ 70,285                  
Supera Pharmaceuticals Inc [Member]                    
Operating Lease Right-of-Use Assets       527,195            
Trade and Other Payables       24,600            
Operating Lease Liability, net of current       $ 46,369            
STOCKHOLDERS’ DEFICIT                    
Common Stock, No Par Value       $ 0.0001            
Common Stock, Shares Authorized       100,000,000            
Common Stock, Shares, Issued       73,991,413            
Common Stock, Shares, Outstanding       73,991,413            
Additional Paid in Capital       $ 1            
Accumulated Deficit       223            
Due from Affiliate, Current       24,600            
Due to Related Parties, Current       39,177            
Interest Payable, Current       175,679            
Accounts Payable, Interest-bearing, Noncurrent       29,628            
Operating Lease, Liability       481,049            
Pro Forma [Member]                    
Cash       133,733            
Prepaid expenses       1,218            
Due from affiliate                  
Total Current Assets       134,951            
Operating Lease Right-of-Use Assets                  
Intangible Assets, net                  
Total Non-Current Assets                  
Total Assets       134,951            
Trade and Other Payables       1,025,063            
Due to Related Party       39,177            
Interest Payable, related party       175,679            
Loan Payable       1,200,000            
Operating Lease Payable                  
Paycheck Protection Program Loan       54,000            
Total Current Liabilities       2,493,919            
Line of Credit Payable – related party, net of discount       1,734,237            
Interest Payable, related party                  
Operating Lease Liability, net of current                  
Total Non-Current Liabilities       1,734,237            
Total Liabilities       4,228,156            
STOCKHOLDERS’ DEFICIT                    
Common stock, par $0.0001, 100,000,000 shares authorized and 73,991,413 issued and outstanding as of December 31, 2020       4,004            
Additional Paid in Capital       43,411,488            
Accumulated Deficit       (47,508,697)            
Total Stockholders’ Equity (Deficit)       (4,093,205)            
Total Liabilities and Stockholders’ Equity (Deficit)       134,951            
Pro Forma [Member] | Supera Pharmaceuticals Inc [Member]                    
Cash       14,551            
Prepaid expenses                  
Due from affiliate       24,600            
Total Current Assets       39,151            
Operating Lease Right-of-Use Assets                  
Intangible Assets, net                  
Total Non-Current Assets                  
Total Assets       39,151            
Trade and Other Payables       556,781            
Due to Related Party                  
Interest Payable, related party                  
Loan Payable                  
Operating Lease Payable                  
Paycheck Protection Program Loan       16,600            
Total Current Liabilities       573,381            
Line of Credit Payable – related party, net of discount       599,747            
Interest Payable, related party       29,628            
Operating Lease Liability, net of current                  
Total Non-Current Liabilities       629,375            
Total Liabilities       1,202,756            
STOCKHOLDERS’ DEFICIT                    
Common stock, par $0.0001, 100,000,000 shares authorized and 73,991,413 issued and outstanding as of December 31, 2020                  
Additional Paid in Capital                  
Accumulated Deficit       (1,163,605)            
Total Stockholders’ Equity (Deficit)       (1,163,605)            
Total Liabilities and Stockholders’ Equity (Deficit)       39,151            
Adjustments [Member]                    
Cash                  
Prepaid expenses                  
Due from affiliate       (24,600)            
Total Current Assets       (24,600)            
Operating Lease Right-of-Use Assets       527,195            
Intangible Assets, net                  
Total Non-Current Assets       527,195            
Total Assets       502,595            
Trade and Other Payables       219,885            
Due to Related Party       (39,177)            
Interest Payable, related party       (175,679)            
Loan Payable                  
Operating Lease Payable       481,049            
Paycheck Protection Program Loan                  
Total Current Liabilities       486,078            
Line of Credit Payable – related party, net of discount                  
Interest Payable, related party       (29,628)            
Operating Lease Liability, net of current       46,369            
Total Non-Current Liabilities       16,741            
Total Liabilities       502,819            
STOCKHOLDERS’ DEFICIT                    
Common stock, par $0.0001, 100,000,000 shares authorized and 73,991,413 issued and outstanding as of December 31, 2020                  
Additional Paid in Capital       (1)            
Accumulated Deficit       (223)            
Total Stockholders’ Equity (Deficit)       (224)            
Total Liabilities and Stockholders’ Equity (Deficit)       $ 502,595